From Verus to Meritage: A Biotech Prototype for Tough Economic Times
By
Christopher Morrison / Email the Author / START-UP March 2009, Vol. 14, No. 3
Venture Round / Word Count: 1294 / Article # 2009900055
Executive Summary
Prolific entrepreneur Cam Garner has a new model for start-ups. Gone are the days of raising huge A rounds to build commercial infrastructure and license in families of products. His two new firms, Meritage and Evoke, are narrowly focused on single assets, in each case a reformulation of an approved drug repositioned in an underserved specialty indication.
$85.00
Buy Now
For $85.00, purchase this 1294-word article and receive immediate online access. 100% Satisfaction Guarantee.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.